Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Open-Labeled Study of the Administration of Allogenic and Autologous Regulatory Cells for the Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor)

NCT00223067 is registered in ClinicalTrials.gov with University Hospital Schleswig-Holstein as lead sponsor.

NCT NCT00223067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00223067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Open-Labeled Study of the Administration of Allogenic and Autologous Regulatory Cells for the Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor)
Lead sponsor
University Hospital Schleswig-Holstein
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2005
Completion date
May 31, 2006
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation